HomePortfoliosAvantis Global Developed Market Equity (AVWC)

Avantis Global Developed Market Equity (AVWC)

A 100% AVWC portfolio which offers simple, global developed-market exposure (large/mid/small caps, ~99% coverage via MSCI World IMI style), set-and-forget diversification with factor premiums baked in, no rebalancing needed. Ideal for EU buy-and-hold investors.
It is an actively managed UCITS ETF, not an index‑tracking fund.

A two‑fund version with emerging markets included, Active Avantis global all‑cap equity portfolio.

None Rebalancing
EUR
Moderate Risk
1.6yr backtest

Performance Summary

Total Return+28.29%
Annualized Return+16.86%
Volatility+15.10%
Sharpe Ratio0.98
Max Drawdown+21.65%

Holdings

Asset Allocation

Asset Class

Equity 100.0%
Holdings Details
AVWC ETF portfolio for EU investors: simple global diversification with factor premiums, no rebalancing needed. Set and forget.
AssetTypeAllocationTER
AVWC.XETRA
Avantis Global Equity UCITS ETF USD AccIE000RJECXS5
ETF
100.0%0.22%
Total100.0%0.22%

Performance

Portfolio Value Over Time
Starting with 10,000 investment → now worth €12,829.02
Histogram of Monthly Returns
The portfolio had a positive return during 15 of the 20 months (75%)
Monthly Returns Heatmap
Best month: +8.3% • Worst month: -7.4% • Best year: 2026 (+10.5%) • Worst year: 2024 (+6.5%)
YearJanFebMarAprMayJunJulAugSepOctNovDecTotal
2026+2.3%+3.3%-4.8%+7.8%+1.8%-------+10.5%
2025+4.9%-2.4%-7.4%-4.6%+6.4%+0.7%+4.6%+0.6%+1.9%+3.1%+1.0%+0.8%+9.1%
2024---------+1.1%+8.3%-2.9%+6.5%
> +2%
0% to +2%
-2% to 0%
< -2%
Drawdown Analysis
Maximum drawdown: +21.65% • The longest drawdown period lasted for 7 months and was between February 2025 and October 2025. It reached a trough of -21.6%.

Detailed Metrics

Returns
Total Return
+28.29%
Annualized Return
+16.86%
Avg Monthly Return
+1.33%
Risk
Volatility (Annual)
+15.10%
Max Drawdown
+21.65%
Positive Months
75%
Average Drawdown
-4.1%
Risk-Adjusted
Sharpe Ratio
0.98
Risk-free rate: 2.0%
Sortino Ratio
0.91
Downside risk adjusted
Return/Volatility
1.12
Calmar Ratio
0.78
Return/Max Drawdown
Ulcer Index
5.50
Drawdown depth & duration
Martin Ratio
0.03
Return/Ulcer Index
Backtest Configuration
Initial Investment
10,000
Final Value
12,829.02
Backtest Period
2024-10-01 to 2026-05-08
1.6 years
Rebalancing
none
Base Currency
EUR